AMBKA SABIKI: Open Payments
NPI 1962781716 · BERKELEY HEIGHTS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 10 payments from 6 companies in 2025. Trend: 2023 $670 · 2024 $348 · 2025 $702
Food & beverage: $702
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. | 4 | $194 |
| GENZYME CORPORATION | 2 | $147 |
| Pharming Healthcare, Inc. | 1 | $124 |
| Regeneron Healthcare Solutions, Inc. | 1 | $114 |
| Optinose US, Inc. | 1 | $104 |
| Greer Laboratories, Inc. | 1 | $19 |
Products named: DUPIXENT, NEFFY, Xhance, ORALAIR.
Industry payments across NJ — which companies pay providers there.
